The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.
Source: MarketWatch
Wednesday, 17. December 2025
Share:
16. December 2025 13:47
Here’s why Pfizer is revising its revenue forecasts
